Alright folks, QNTM is putting on a clinic right now with this textbook ascending triangle breakout at $23.25. This isn't just some random chart move - there's serious firepower behind this surge:

* **Unbuzzd's $5M cash infusion** (Reg D, non-dilutive = no share dilution)
* **Lucid-MS Phase 2 trial moving faster than expected** (thanks to PET-MRI efficiency)
* **$1.2M quarterly royalties** keeping the lights on
* That juicy **$700M legal payout** still in play

Here's why this breakout is so explosive: with less than 3M shares floating around, even modest buying pressure can send this thing parabolic. We've seen it happen before with similar setups.

**Trade Strategy:**

* **Entry:** $23.40-23.50 looks solid for a position
* **Stop Loss:** Tight at $23.10 (protect your capital)
* **Target:** $25.00 is the obvious next level (could hit soon)

The beauty here? Both the technicals AND fundamentals are aligned. The chart gave us the signal, and the news flow confirms the momentum. This is one of those rare setups where everything clicks.

Who's riding this wave? Let me know your thoughts below! And as always - manage your risk, folks. Even the best setups can turn.









OI ELPW PYPL CAT EME HWH LMT CBFV MU MSTR GS CMCSA GTLS CRM CG LITE TYGO WLDN VERU V ACN SBEV FTAI W VRSN RNGR GMS PHIN JCI STAI FUBO SRPT IMNN GM HSPT NVNI FIX TOYO PTIX OP SPTN ALNY PTON GPRE APH CGON PG GNTX URGN TEL UNH BSY MCD SNGX MGRM COSM CHTR CLSD XGN BGLC CECO TACH GLW NXGL PWR PGEN RCL DDOG KO BA RCON ADBE IONQ NMRK BSGM CSCO CVX AVGO BAX TRMB AGH KORE WHR ADIL ELAB IONS SOFI B MTRX REPL MRK MRVL GEV STX NSC ORCL ACFN BAC SGBX CFLT SANM ANET TLIH JPM WMT TRML F LC HOG SGD BRO GHLD NCRA NVDA ACRS HCTI MRT INTC VFC DY VIGL GRNQ YORK EXFY ELTX AZZ HIMS MMC FHI APLD NCLH NBIS RSLS GE UUU RCKY MIRM BE COIN STFS QQQ AJG V ECOR RGTI CBRE ALGN SBUX MPU AWI DDC CPHI NOW ARCT VRM TNL RMD CTSO SCLX VIVK NET TMO FGF TGEN ETSY IXHL GCL BMY AMKR CRWD ANPA IVZ GTX AAPL QRVO HCAI WFC CSX PLTR BNRG DRRX CMG BKNG MCVT UNP GRMN XAIR BLKB GOOG VRSK SNSE NIXX CENN LRCX CAPR

Why QNTM's $25 Target Looks Like Easy Money Right Now